Informations

Stand number

D96

Exhibition class

M: Medicine – Surgery – Orthopaedics – Material for disabled

Technical description

New prototypes of therapeutic CD9 antibody are generated by Fc engineering with potent activities against refractory leukemia and excellent safety profiles. Toxicity of CD9 antibodies, a longstanding hurdle for clinical translation, is resolved.

Simplified description

Newly designed CD9 antibodies show promise against hard-to-treat leukemia with improved safety and fewer side effects, overcoming previous challenges in therapy development.